Brochure
16 May 2021

Clinical Development & cGMP Manufacturing Services 2021

PDF 313 kB
Download

Eurofins CDMO is an FDA-approved contract development and manufacturing organization (CDMO) focused on API and Drug Product development and manufacturing services for complex small molecules. IND enabling development of poorly soluble compounds and clinical manufacturing strategies are a core strength at Eurofins CDMO.

Content provided by our supplier

Eurofins CDMO Alphora Inc

  • CA
  • 2015
    On CPHI since
  • 3
    Certificates
Company types
Contract Service
Manufacturer/Innovator
View company profile

Other Content from Eurofins CDMO Alphora Inc (3)

  • News Sip N' Science Mixer with Eurofins CDMO Alphora Inc.

    Join us for an afternoon of science, cocktails and networking at our Sip N Science Mixer on Wednesday, May 9 from 2:00 pm - 4:00 at Booth#414. 

    We look forward to seeing you there!
    1 May 2024
  • Analytical Services 2021

    Brochure Analytical Services 2021

    Eurofins CDMO offers analytical services as part of API development as well as stand-alone analytical testing services for projects at various stages in the drug life cycle (pre-clinical to late phase). Our analytical scientists specialize in the development of analytical methods and phase appropriate specifications to ensure control of the synthetic process and quality of API throughout the program.
  • API Developmental Services 2021

    Brochure API Developmental Services 2021

    Eurofins CDMO is an FDA-approved contract development and manufacturing organization (CDMO) focused on process chemistry, cGMP scale-up and analytical method development for complex, small molecule APIs, including highly potent molecules.